Blockchain Registration Transaction Record

Key Molecular Pathway Driving Spinal Cord Scarring Identified

Study identifies c-Jun–Irf8–CD36 axis as key driver of fibrotic scarring after spinal cord injury. Targeting CD36 or c-Jun reduces scar formation, improves regeneration and motor recovery in mice.

This research matters because it identifies a specific molecular cascade—c-Jun–Irf8–CD36—that can be targeted to modulate fibrotic scarring after spinal cord injury, potentially leading to new treatments that improve functional recovery. Instead of removing scars, which can be harmful, the approach aims to fine-tune scar formation at the right stage, preserving early protective effects while preventing long-term barriers to nerve regeneration. For the millions affected by spinal cord injuries worldwide, this offers hope for therapies that address a root cause of poor recovery.